The article on prescribing for transgender patients (Aust Prescr 2019;42:10-3) has been corrected.
In the second paragraph of the ‘Monitoring’ section, the target estradiol level for transwomen on treatment should be 400–700 pmol/L (not 400–700 mmol/L).